Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Human medicines: European public assessment reports (EPARs)

Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.

Follow now 249 followers

Latest posts

Last updated 3 days ago

Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of...

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Date of authorisation: 26/08/1997, Revision: 48, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Date of authorisation...

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 15, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation...

Summary of opinion: Simparica Trio, 12/02/2025 Positive

3 days ago

Summary of opinion: Simparica Trio, 12/02/2025 Positive

Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 7, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro...

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation: 26/06/2023, Revision: 3, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Opfolda, miglustat, Date of authorisation...

Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation: 07/12/2023, Revision: 3, Status: Authorised

3 days ago

Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation...

Human medicines European public assessment report (EPAR): Bortezomib Fresenius Kabi, bortezomib, Date of authorisation: 14/11/2019, Revision: 7, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Bortezomib Fresenius Kabi, bortezomib, Date...

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Date of authorisation: 22/05/2012, Revision: 19, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Docetaxel Accord, docetaxel, Date of...

Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 1, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Dimethyl fumarate Neuraxpharm, dimethyl fumarate...

Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation: 20/06/2022, Revision: 2, Status: Authorised

4 days ago

Human medicines European public assessment report (EPAR): Tabrecta, capmatinib, Date of authorisation...